# Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children

> **NCT02072174** · PHASE4 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 569 (actual)

## Conditions studied

- Influenza and Acute Respiratory Viral Infections

## Interventions

- **DRUG:** Anaferon for Children

## Key facts

- **NCT ID:** NCT02072174
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-08
- **Primary completion:** 2018-04-16
- **Final completion:** 2018-04-16
- **Target enrollment:** 569 (ACTUAL)
- **Last updated:** 2019-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02072174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02072174, "Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02072174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*